John Slebir reports a stock award at ARS Pharmaceuticals
By AlphaYouPublished Form 4
Slebir John L
Reporting filer
John Slebir reports a stock award, not an open-market purchase or sale, in ARS Pharmaceuticals, Inc.. Form 4 filed Nov 4, 2026 lists 1 entry.
- Disclosed
- Nov 4, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) (derivative) | Slebir John L | 2026-11-02 | A | Grant or award | 1199482 | 0 | 1,199,482 | 2 days | Filed terms
|
Stock Option (right to buy) (derivative)
- Owner
- Slebir John L
- Date
- 2026-11-02
- Code
- A
- Action
- Grant or award
- Quantity
- 1199482
- Price
- 0
- Following holdings
- 1,199,482
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 3.05
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 1199482
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-01
- underlying Security Title: Common Stock
- underlying Security Shares: 1199482
- shares Owned Following Transaction: 1199482
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Slebir John L: Chief Legal Officer.
- F1: 25% of the shares subject to the option vest on October 26, 2027, and the remaining shares will vest monthly thereafter over three years.
Original sources
Prepared automatically from public filing data. Report a correction.